These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28629718)

  • 1. Changes in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.
    Kim EY; Roshanravan H; Dryer SE
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2342-2354. PubMed ID: 28629718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases.
    Kim EY; Hassanzadeh Khayyat N; Dryer SE
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3527-3536. PubMed ID: 30293571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
    Staeck O; Slowinski T; Lieker I; Wu K; Rudolph B; Schmidt D; Brakemeier S; Neumayer HH; Wei C; Reiser J; Budde K; Halleck F; Khadzhynov D
    Transplantation; 2015 Dec; 99(12):2593-7. PubMed ID: 26371597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE and αVβ3-integrin are essential for suPAR signaling in podocytes.
    Kim EY; Dryer SE
    Biochim Biophys Acta Mol Basis Dis; 2021 Oct; 1867(10):166186. PubMed ID: 34166766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPC6 and FSGS: the latest TRP channelopathy.
    Mukerji N; Damodaran TV; Winn MP
    Biochim Biophys Acta; 2007 Aug; 1772(8):859-68. PubMed ID: 17459670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of podocin on the gating of podocyte TRPC6 channels evoked by membrane stretch or diacylglycerol.
    Anderson M; Kim EY; Hagmann H; Benzing T; Dryer SE
    Am J Physiol Cell Physiol; 2013 Aug; 305(3):C276-89. PubMed ID: 23657570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
    PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel gain-of-function mutation in transient receptor potential C6 that causes podocytes injury.
    Yu M; Hu J; Ju T; Wang R; Wang M; Gao C; Xia Z
    Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):284-288. PubMed ID: 38814201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. suPAR and chronic kidney disease-a podocyte story.
    Zeier M; Reiser J
    Pflugers Arch; 2017 Aug; 469(7-8):1017-1020. PubMed ID: 28689240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleiotropic signaling evoked by tumor necrosis factor in podocytes.
    Abkhezr M; Kim EY; Roshanravan H; Nikolos F; Thomas C; Hagmann H; Benzing T; Dryer SE
    Am J Physiol Renal Physiol; 2015 Jul; 309(2):F98-108. PubMed ID: 26017975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
    Cara-Fuentes G; Araya C; Wei C; Rivard C; Ishimoto T; Reiser J; Johnson RJ; Garin EH
    Nefrologia; 2013; 33(5):727-31. PubMed ID: 24089165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease.
    Yoo TH; Pedigo CE; Guzman J; Correa-Medina M; Wei C; Villarreal R; Mitrofanova A; Leclercq F; Faul C; Li J; Kretzler M; Nelson RG; Lehto M; Forsblom C; Groop PH; Reiser J; Burke GW; Fornoni A; Merscher S
    J Am Soc Nephrol; 2015 Jan; 26(1):133-47. PubMed ID: 24925721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events.
    May CJ; Chesor M; Hunter SE; Hayes B; Barr R; Roberts T; Barrington FA; Farmer L; Ni L; Jackson M; Snethen H; Tavakolidakhrabadi N; Goldstone M; Gilbert R; Beesley M; Lennon R; Foster R; Coward R; Welsh GI; Saleem MA
    Kidney Int; 2023 Aug; 104(2):265-278. PubMed ID: 36940798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct effect of plasma permeability factors from patients with idiopatic FSGS on nephrin and podocin expression in human podocytes.
    Doublier S; Musante L; Lupia E; Candiano G; Spatola T; Caridi G; Zennaro C; Carraro M; Ghiggeri GM; Camussi G
    Int J Mol Med; 2005 Jul; 16(1):49-58. PubMed ID: 15942677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP acting through P2Y receptors causes activation of podocyte TRPC6 channels: role of podocin and reactive oxygen species.
    Roshanravan H; Dryer SE
    Am J Physiol Renal Physiol; 2014 May; 306(9):F1088-97. PubMed ID: 24553432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
    Agrawal V; Prasad N; Jain M; Pandey R
    Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
    Wei C; El Hindi S; Li J; Fornoni A; Goes N; Sageshima J; Maiguel D; Karumanchi SA; Yap HK; Saleem M; Zhang Q; Nikolic B; Chaudhuri A; Daftarian P; Salido E; Torres A; Salifu M; Sarwal MM; Schaefer F; Morath C; Schwenger V; Zeier M; Gupta V; Roth D; Rastaldi MP; Burke G; Ruiz P; Reiser J
    Nat Med; 2011 Jul; 17(8):952-60. PubMed ID: 21804539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.